Top 50 Genomic Sequencing

The startup develops a single-cell sequencing technology that utilizes patented split-pool barcoding and combinatorial indexing methods to enhance sample indexing and cell throughput. This technology enables researchers to conduct a wide range of genomic, epigenomic, transcriptomic, and proteogenomic analyses efficiently.

Nebula Genomics offers Whole Genome Sequencing that decodes 100% of an individual's DNA, providing comprehensive insights into health risks, ancestry, and genetic traits. Utilizing blockchain technology, the platform ensures users maintain full ownership and privacy of their genomic data while receiving regular updates based on the latest scientific research.

Provides an integrated platform for low-pass whole genome sequencing, combining assay development, scalable sequencing, and cloud-based data analytics to deliver cost-effective genomic insights. Enables applications in human, plant, and animal genomics, such as predicting disease risk, identifying genetic traits, and optimizing breeding strategies, while streamlining data processing and management for researchers and industry professionals.

Intelliseq provides a cloud-based platform for automated analysis and clinical interpretation of Next Generation Sequencing (NGS) genetic data, enabling users to generate actionable insights without requiring bioinformatics expertise. The platform addresses the need for efficient and accurate genomic diagnostics by offering customizable workflows for various medical applications, including diagnostics, therapy, and prevention.

Vitract utilizes genomic sequencing to analyze gut microbiome composition and identify biomarkers that impact digestive, metabolic, and mental health. By combining gut testing with personalized nutrition coaching, Vitract addresses the root causes of mental illness and promotes overall wellness through tailored dietary recommendations.

This company offers genomic data interpretation services to identify optimal cancer therapies based on individual patient sequencing. Their platform analyzes genomic data to provide personalized insights for cancer treatment and risk assessment. By combining data integration, predictive modeling, and visualization, they enable doctors to tailor surveillance and risk-reduction strategies for patients.

Loop Genomics provides a platform for long-read DNA sequencing that enhances genomic research by integrating advanced target capture workflows. This technology addresses the need for high-accuracy sequencing at lower costs, enabling researchers to obtain reliable data efficiently.

Nucleus offers whole-genome sequencing that analyzes 100% of an individual's DNA, providing insights into genetic risks for over 800 health conditions, including cancers and heart disease. This technology enables users to understand their unique genetic predispositions and make informed lifestyle choices to enhance their health outcomes.

Plasmidsaurus provides fast and accurate sequencing services for plasmids, RNA, amplicons, and genomes. They simplify complex workflows by offering outsourcing for technical sequencing headaches and providing intuitive bioinformatics tools for data analysis. This service allows researchers to focus on their science by delivering publication-grade results quickly without requiring capital investment in sequencing hardware.

Watchmaker Genomics develops high-performance enzymes and library preparation kits for next-generation sequencing (NGS) applications, addressing the limitations of current reagents that hinder accurate genomic analysis. Their products enhance throughput and sensitivity for a range of applications, including single-cell sequencing and CRISPR-based editing, enabling researchers to obtain reliable data from diverse sample types.

PetDx is a molecular diagnostics company that utilizes advanced genomic sequencing techniques to detect cancer in pets at an early stage. By providing accurate and timely diagnoses, PetDx enables veterinarians to implement targeted treatment plans, improving outcomes for affected animals.

Sequentify develops the InfiniSeq™ workflow and InfiniSeqKit for genomic sample processing, focusing on efficient library preparation for next-generation sequencing. By reducing the cost and complexity of sample preparation, Sequentify addresses the significant expense and bottleneck in the sequencing process, enabling scalable genomic diagnostics and therapeutics.

Inocras Inc. utilizes whole genome sequencing and a proprietary bioinformatics platform to provide detailed genetic insights for patients with cancer and rare diseases. This technology identifies complex mutations often missed by standard tests, enabling more accurate diagnoses and personalized treatment options.

4baseCare develops precision oncology solutions utilizing next-generation sequencing and comprehensive genomic profiling to identify specific cancer mutations in patients. Their technology addresses the need for personalized treatment options by providing tailored insights that enhance therapeutic decision-making for cancer care in the Indian population.

54gene provides a genetics testing platform that utilizes next-generation sequencing technology to analyze DNA samples for genetic variations. This service enables healthcare providers to identify hereditary conditions and tailor personalized treatment plans, improving patient outcomes in genetic healthcare.

SeqOne provides a clinical decision support platform that utilizes AI-driven bioinformatics to analyze next-generation sequencing (NGS) data for germline and somatic variants. The platform enhances diagnostic accuracy and efficiency by identifying complex genomic events that standard pipelines often overlook, thereby improving patient outcomes in precision medicine.

Cradle Genomics has developed a novel prenatal testing methodology that utilizes advanced genomic sequencing techniques to detect genetic abnormalities in fetuses. This technology provides expectant parents with early and accurate information about potential health issues, enabling informed decision-making during pregnancy.

This startup offers next-day plasmid sequencing services with integrated bioinformatics analysis. Their platform provides high-throughput, quality, and cost-effective sequencing, supporting bioscience research globally.

Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.

Wasatch Biolabs provides advanced native-read sequencing services utilizing Oxford Nanopore technology for genomic and epigenomic analysis. The company specializes in proprietary platforms like Direct Whole Methylome Sequencing (dWMS) to deliver high-resolution methylation and variant profiling without bisulfite conversion. These scalable solutions support applications ranging from early biomarker discovery to clinical-ready precision diagnostics.

MGI Tech develops genetic sequencers and lab automation tools that enhance genomic analysis and streamline sample preparation processes in life sciences. Their technology addresses the need for efficient, high-throughput sequencing and data management, enabling precise diagnostics and research in healthcare and agriculture.

This startup develops a platform that integrates advanced genomic technologies for diagnostics, prognostics, and therapeutic development. It offers genetic testing and counseling to diagnose and treat rare diseases, enabling personalized care for patients.

This startup offers a genomic diagnostics platform that utilizes DNA sequencing technology to detect genetic disorders and predispositions. By providing accurate genetic data, it enables healthcare providers to tailor patient care based on individual genetic profiles.

Accuragen provides a cloud‑based genomics platform that automates the full sequencing workflow, from library preparation to bioinformatics analysis, delivering high‑throughput, high‑quality DNA data. The service offers secure, HIPAA‑compliant storage, web‑portal and API access, and scalable pricing for research labs, clinical genetics centers, and pharmaceutical R&D teams, eliminating the need to manage complex sequencing infrastructure.

This startup offers whole genome sequencing and genetic testing services to identify health risks and inform personalized medicine. They provide genetic counseling and bioinformatics tools to patients and healthcare providers for accurate genetic analysis.

The startup utilizes microbial biomarkers, liquid biopsy technology, genomic sequencing, and bioinformatics to detect cancer-associated microbes in blood samples. This approach enables early-stage cancer detection, improving patient outcomes by facilitating timely medical intervention.

This startup offers whole genome sequencing technology that analyzes 100% of an individual's DNA, providing detailed insights into health risks, medication responses, and nutritional needs. By delivering personalized reports based on genetic data, the company empowers users to make informed health decisions and improve their overall well-being.

Variantyx provides whole‑genome sequencing on a single platform that delivers both targeted gene panels and automatic reflex to comprehensive analysis without additional samples. Their AI/ML‑driven pipeline detects a broad spectrum of variant types—including structural rearrangements and repeat expansions—to achieve high diagnostic yield for rare diseases, prenatal genetics, and precision oncology. The service includes CLIA‑ and CAP‑certified lab processing, flexible billing, and clinical support for laboratories and specialty physicians.

The startup specializes in DNA sequencing technologies, offering short-read sequencers that deliver ultra-long-range results for diploid genomes of various sizes. This capability enables precise applications such as de novo sequencing and structural variation detection, allowing businesses to efficiently generate customizable sequencing libraries tailored to their specific genomic needs.

The startup operates a cancer diagnostic laboratory that provides genomic profiling for solid and hematologic cancers, utilizing next-generation sequencing technologies to deliver precise genetic insights. By partnering with laboratories, hospitals, and oncology practices, the company enhances diagnostic accuracy and treatment personalization for cancer patients.

The startup develops a therapy product utilizing genomics and genetic sequencing technologies to enhance the efficacy of tumor treatments through optimized cell therapy strategies. By leveraging bioinformatics and data mining, the company aims to provide personalized and effective therapies for cancer patients, improving treatment outcomes.

The startup specializes in genomics sequencing focused on non-European genomes, utilizing modern and ancient DNA analysis across various sequencing platforms. By providing a diverse genomic database and biobank, the company enables pharmaceutical firms to enhance drug development through insights into disease predisposition and pharmacogenomics.

The startup develops rapid diagnostics kits that utilize next-generation sequencing methods, including a 16S NGS library preparation kit for rRNA sequencing and quantification kits for DNA libraries and human gDNA. These tools enable scientists to accurately identify multiple bacterial species in mixed populations, facilitating faster disease detection across various platforms.

The startup develops a genomics platform that enhances genetic testing accuracy by analyzing the functional significance of genetic variations and mutations in the human genome. This technology enables improved interpretation of genetic tests for rare diseases and cancer, facilitating the conversion of generic drugs into targeted precision medicines.

XGenomes develops DNA sequencing technologies that utilize optical super-resolution imaging and machine learning to monitor health, detect early disease signals, and track interventions throughout an individual's life. Their platform addresses high error rates and complex workflows in existing sequencing methods, providing a streamlined and cost-effective solution for continuous health monitoring.

INanoBio is building a 3D nanopore‑transistor sequencing platform on CMOS technology that can read whole human genomes with high accuracy at roughly one‑tenth the current cost and over 100 × faster than existing protein nanopore sequencers.

Grandomics specializes in third-generation sequencing technology to provide molecular diagnostics and carrier screening for single-gene diseases. Their platform enables accurate detection of genetic variations and complex genomic regions, facilitating precise diagnosis and research in genetic disorders.

Veil Genomics develops advanced genomic sequencing technologies to accelerate disease research and drug discovery. Their platform provides high-throughput, accurate genetic data analysis, enabling scientists to identify biomarkers and therapeutic targets more efficiently.

The startup provides plasmid sequencing services using nanopore technology to ensure high-quality results with rapid turnaround times. Their offerings include validating plasmid insert orientation and backbone integrity, which helps researchers in academia and the pharmaceutical industry avoid contamination and primer issues.

The startup develops precision diagnostics technology that enhances benchtop scale sequencers for liquid biopsies, enabling efficient detection of oncology and infectious diseases. By removing barriers to global access, the company increases the availability of molecular diagnostic tests for healthcare professionals.

Aegicare is an AI-driven platform that provides clinical whole-genome sequencing solutions, utilizing proprietary bioinformatics tools to deliver precise genetic analysis and rare disease interpretation. The platform addresses the challenge of accurate diagnosis in complex genetic conditions, enhancing patient care through tailored genomic insights.

Moonlight AI provides an AI diagnostics platform that democratizes access to genomic information for personalized medicine in hematologic cancers. The platform uses computer vision to identify genomic aberrations directly from blood or bone marrow smears, significantly reducing the time and cost of traditional Next-Generation Sequencing (NGS) testing. This enables faster diagnosis, response assessment, and continuous treatment optimization for individual cancer patients.

Praxis Genomics provides advanced clinical genetic testing by integrating Whole Genome Sequencing, Optical Genome Mapping, and Transcriptome Sequencing for comprehensive genomic analysis. This multi-omic approach achieves high diagnostic sensitivity for unsolved genetic disorders and detailed cancer profiling. The company supports clinical decisions through expert genetic consulting and offers these advanced platforms for basic science research applications.

Foresee Genomics provides comprehensive next-generation sequencing (NGS) solutions, including protocols, reagents, and bioinformatics tools, to make high-accuracy genomic analysis accessible to smaller laboratories. Their technology enables labs to perform rapid, accurate diagnostics with minimal investment and small sample requirements. This accessibility accelerates timely genomic testing, supporting precision medicine and enhancing patient care outcomes.

Axbio develops a high-throughput Bio-CMOS platform for next-generation gene sequencing and molecular diagnostics, utilizing nanopore sequencing technology for real-time, single-molecule analysis. Their solutions address the need for rapid and accurate genomic data generation, enhancing diagnostic capabilities in healthcare and research.

The startup develops a bioinformatics platform that utilizes DNA sequence manipulation techniques, including alignment, variant calling, and functional annotation, to identify genes associated with specific functions. This enables biotechnology and pharmaceutical companies to conduct mutational analysis for verifying genetic modifications, thereby enhancing product design and accelerating research timelines.

The startup has developed a spatial gene sequencing technology that integrates microscope imaging with genomic data to provide single-cell resolution expression profiling in tissue samples. This platform enables clinical researchers to identify the spatial distribution and interactions of cell types, facilitating the discovery of key marker genes for potential drug targets in cancer research and other diseases.

Biostate AI integrates biological samples, multi-omics data, and AI to advance precision health solutions globally. The company develops proprietary sequencing technologies, such as BIRT and PERD, to generate cleaner, cost-effective genomic data for earlier disease detection. Through subsidiaries, Biostate AI focuses on population-scale health management, autonomous scientific research, and intelligent diagnostics implementation.

NGX Bio is an online marketplace that connects researchers with DNA sequencing services, offering next-generation sequencing and bioinformatics in a CLIA/CLEP and CAP accredited environment. The platform addresses the need for reliable, high-quality sequencing solutions by providing fast turnaround times and expert scientific support tailored to diverse research projects.

Shirebio develops custom software pipelines for sequencing data analysis, utilizing a natural language interface tailored for genomics applications. This technology simplifies complex data interpretation, enabling researchers to efficiently analyze genomic sequences without extensive programming knowledge.